These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15449047)

  • 1. Evidence of increased chromosomal abnormalities in French Polynesian thyroid cancer patients.
    Violot D; M'Kacher R; Adjadj E; Dossou J; de Vathaire F; Parmentier C
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):174-9. PubMed ID: 15449047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased rate of dicentric chromosomes in French Polynesian thyroid cancer patients?
    Pauwels EK
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):382; author reply 383. PubMed ID: 16292628
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma.
    M'Kacher R; Legal JD; Schlumberger M; Voisin P; Aubert B; Gaillard N; Parmentier C
    J Nucl Med; 1996 Nov; 37(11):1860-4. PubMed ID: 8917193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic biodosimetry and dose-rate effect after radioiodine therapy for thyroid cancer.
    Khvostunov IK; Saenko VA; Krylov V; Rodichev A; Yamashita S
    Radiat Environ Biophys; 2017 Aug; 56(3):213-226. PubMed ID: 28526978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
    de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM
    J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of short-term chromosomal damage due to therapeutic 131I exposure in patients with thyroid cancer.
    Hernández-Jardines A; Molina B; del Castillo V; Papadakis M; Rivera T; Azorín J; Herrera LA; Yokoyama E; Frías S
    Rev Invest Clin; 2010; 62(1):31-8. PubMed ID: 20415057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic and dosimetric effects of (131)I in patients with differentiated thyroid carcinoma: comparison between stimulation with rhTSH and thyroid hormone withdrawal treatments.
    da Silva MA; Valgôde FG; Gonzalez JA; Yoriyaz H; Guimarães MI; Ribela MT; Buchpiguel CA; Bartolini P; Okazaki K
    Radiat Environ Biophys; 2016 Aug; 55(3):317-28. PubMed ID: 27013085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytogenetic study of thyroid patients treated with external irradiation or radioiodine].
    Katz N; Esik O; Füzy M; Gundy S
    Orv Hetil; 1998 Jun; 139(25):1521-6. PubMed ID: 9676113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay.
    Watanabe N; Yokoyama K; Kinuya S; Shuke N; Shimizu M; Futatsuya R; Michigishi T; Tonami N; Seto H; Goodwin DA
    J Nucl Med; 1998 Mar; 39(3):436-40. PubMed ID: 9529288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma.
    M'Kacher R; Légal JD; Schlumberger M; Aubert B; Beron-Gaillard N; Gaussen A; Parmentier C
    J Nucl Med; 1997 Mar; 38(3):377-80. PubMed ID: 9074522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome aberrations after treatment with radioactive iodine for thyroid cancer.
    Baugnet-Mahieu L; Lemaire M; Léonard ED; Léonard A; Gerber GB
    Radiat Res; 1994 Dec; 140(3):429-31. PubMed ID: 7972697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients. Dosimetry-based model for estimation.
    Jentzen W; Moldovan AS; Ruhlmann M; Görges R; Bockisch A; Rosenbaum-Krumme S
    Nuklearmedizin; 2015; 54(3):137-43. PubMed ID: 25987357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased uptake after fractionated ablative doses of iodine-131.
    Wu HS; Hseu HH; Lin WY; Wang SJ; Liu YC
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):167-73. PubMed ID: 15351912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131.
    M'Kacher R; Schlumberger M; Légal JD; Violot D; Béron-Gaillard N; Gaussen A; Parmentier C
    J Nucl Med; 1998 May; 39(5):825-9. PubMed ID: 9591584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equal induction and persistence of chromosome aberrations involving chromosomes 1, 4 and 10 in thyroid cancer patients treated with radioactive iodine.
    Puerto S; Marcos R; Ramírez MJ; Galofré P; Creus A; Surrallés J
    Mutat Res; 2000 Aug; 469(1):147-58. PubMed ID: 10946251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of thyroid cancer after exposure to 131I in childhood.
    Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
    J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary iodine and thyroid cancer risk in French Polynesia: a case-control study.
    Cléro É; Doyon F; Chungue V; Rachédi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Dewailly E; Rubino C; de Vathaire F
    Thyroid; 2012 Apr; 22(4):422-9. PubMed ID: 22280227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy.
    Eberlein U; Scherthan H; Bluemel C; Peper M; Lapa C; Buck AK; Port M; Lassmann M
    J Nucl Med; 2016 Feb; 57(2):173-9. PubMed ID: 26564321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid cancer in French Polynesia between 1985 and 1995: influence of atmospheric nuclear bomb tests performed at Mururoa and Fangataufa between 1966 and 1974.
    de Vathaire F; Le Vu B; Vathaire CC
    Cancer Causes Control; 2000 Jan; 11(1):59-63. PubMed ID: 10680730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavior and Food Consumption Pattern of the French Polynesian Population in the 1960s -1970s.
    Drozdovitch V; Bouville A; Tetuanui T; Taquet M; Gardon J; Xhaard C; Ren Y; Doyon F; de Vathaire F
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3667-3677. PubMed ID: 31870108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.